Starling Oncology, Inc. Shares Outstanding (Cover Page)
Starling Oncology, Inc. (STLN) had Shares Outstanding (Cover Page) of 101.92 million shares as of 2026-07-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-30: Entity Common Stock, Shares Outstanding 101.92M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 99.98M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 98.84M shares.
- 2025-11-06: Entity Common Stock, Shares Outstanding 98.38M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 101.92M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 99.98M shares 10-Q · filed 2026-05-07 |
| 2026-03-05 | 98.84M shares 10-K · filed 2026-03-12 |
| 2025-11-06 | 98.38M shares 10-Q · filed 2025-11-13 |
| 2025-08-06 | 93.50M shares 10-Q · filed 2025-08-13 |
| 2025-05-07 | 89.23M shares 10-Q · filed 2025-05-14 |
| 2025-03-10 | 75.75M shares 10-K · filed 2025-03-26 |
| 2024-11-06 | 75.56M shares 10-Q · filed 2024-11-13 |
| 2024-08-06 | 75.49M shares 10-Q · filed 2024-08-13 |
| 2024-05-07 | 74.44M shares 10-Q/A · filed 2024-05-22 |
| 2024-04-19 | 74.31M shares 10-K/A · filed 2024-05-22 |
| 2024-03-19 | 74.31M shares 10-K · filed 2024-03-28 |
| 2023-11-03 | 73.75M shares 10-Q · filed 2023-11-08 |
| 2023-08-04 | 72.96M shares 10-Q · filed 2023-08-09 |
| 2023-05-05 | 75.35M shares 10-Q · filed 2023-05-10 |
| 2023-03-06 | 74.55M shares 10-K · filed 2023-03-16 |
| 2022-11-04 | 72.34M shares 10-Q · filed 2022-11-09 |
| 2022-08-09 | 72.14M shares 10-Q · filed 2022-08-09 |
| 2022-05-09 | 73.28M shares 10-Q · filed 2022-05-10 |
| 2022-03-10 | 73.25M shares 10-K · filed 2022-03-11 |